These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 16775667

  • 21. Eplerenone : a review of its use in left ventricular systolic dysfunction and heart failure after acute myocardial infarction.
    Keating GM, Plosker GL.
    Drugs; 2004; 64(23):2689-707. PubMed ID: 15537370
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of eplerenone in the subgroup of EPHESUS patients with baseline left ventricular ejection fraction <or=30%.
    Pitt B, Gheorghiade M, Zannad F, Anderson JL, van Veldhuisen DJ, Parkhomenko A, Corbalan R, Klug EQ, Mukherjee R, Solomon H, EPHESUS Investigators.
    Eur J Heart Fail; 2006 May; 8(3):295-301. PubMed ID: 16504579
    [Abstract] [Full Text] [Related]

  • 23. Letter regarding article by Weintraub et al, "Cost-effectiveness of eplerenone compared with placebo in patients with myocardial infarction complicated by left ventricular dysfunction and heart failure".
    Stecker EC, McAnulty JH.
    Circulation; 2005 Aug 02; 112(5):e74. PubMed ID: 16061750
    [No Abstract] [Full Text] [Related]

  • 24. Cost Effectiveness of Eplerenone for the Treatment of Systolic Heart Failure with Mild Symptoms in Alberta, Canada.
    Thanh NX, Ezekowitz JA, Tran DT, Kaul P.
    Am J Cardiovasc Drugs; 2016 Oct 02; 16(5):365-76. PubMed ID: 27300508
    [Abstract] [Full Text] [Related]

  • 25. Aldosterone blockade in post-acute myocardial infarction heart failure.
    Pitt B, Ferrari R, Gheorghiade M, van Veldhuisen DJ, Krum H, McMurray J, Lopez-Sendon J.
    Clin Cardiol; 2006 Oct 02; 29(10):434-8. PubMed ID: 17063946
    [Abstract] [Full Text] [Related]

  • 26. Expanding the outcomes in clinical trials of heart failure: the quality of life and economic components of EPHESUS (EPlerenone's neuroHormonal Efficacy and SUrvival Study).
    Spertus JA, Tooley J, Jones P, Poston C, Mahoney E, Deedwania P, Hurley S, Pitt B, Weintraub WS.
    Am Heart J; 2002 Apr 02; 143(4):636-42. PubMed ID: 11923800
    [Abstract] [Full Text] [Related]

  • 27. Serum sodium and eplerenone use in patients with a myocardial infarction and left ventricular dysfunction or heart failure: insights from the EPHESUS trial.
    Martens P, Ferreira JP, Vincent J, Abreu P, Busselen M, Mullens W, Tang WWH, Böhm M, Pitt B, Zannad F, Rossignol P.
    Clin Res Cardiol; 2022 Apr 02; 111(4):380-392. PubMed ID: 33893561
    [Abstract] [Full Text] [Related]

  • 28. Effect of aldosterone blockade in patients with systolic left ventricular dysfunction: implications of the RALES and EPHESUS studies.
    Pitt B.
    Mol Cell Endocrinol; 2004 Mar 31; 217(1-2):53-8. PubMed ID: 15134801
    [Abstract] [Full Text] [Related]

  • 29. Opposite predictive value of pulse pressure and aortic pulse wave velocity on heart failure with reduced left ventricular ejection fraction: insights from an Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) substudy.
    Regnault V, Lagrange J, Pizard A, Safar ME, Fay R, Pitt B, Challande P, Rossignol P, Zannad F, Lacolley P.
    Hypertension; 2014 Jan 31; 63(1):105-11. PubMed ID: 24126172
    [Abstract] [Full Text] [Related]

  • 30. Usefulness of abnormal heart rate turbulence to predict cardiovascular mortality in high-risk patients with acute myocardial infarction and left ventricular dysfunction (from the EPHESUS study).
    Stein PK, Deedwania P.
    Am J Cardiol; 2009 Jun 01; 103(11):1495-9. PubMed ID: 19463505
    [Abstract] [Full Text] [Related]

  • 31. Eplerenone: a selective aldosterone receptor antagonist for patients with heart failure.
    Barnes BJ, Howard PA.
    Ann Pharmacother; 2005 Jan 01; 39(1):68-76. PubMed ID: 15590870
    [Abstract] [Full Text] [Related]

  • 32. Adherence to aldosterone-blocking agents in patients with heart failure.
    Margolis J, Gerber RA, Roberts C, Gheorghiade M.
    Am J Ther; 2010 Jan 01; 17(5):446-54. PubMed ID: 20844344
    [Abstract] [Full Text] [Related]

  • 33. Cost-effectiveness of aldosterone antagonists for the treatment of post-myocardial infarction heart failure.
    McKenna C, Walker S, Lorgelly P, Fenwick E, Burch J, Suekarran S, Bakhai A, Witte K, Harden M, Wright K, Woolacott N, Palmer S.
    Value Health; 2012 May 01; 15(3):420-8. PubMed ID: 22583451
    [Abstract] [Full Text] [Related]

  • 34. Cost-Effectiveness of Eplerenone Compared to Usual Care in Patients With Chronic Heart Failure and NYHA Class II Symptoms, an Australian Perspective.
    Ademi Z, Pasupathi K, Liew D.
    Medicine (Baltimore); 2016 May 01; 95(18):e3531. PubMed ID: 27149456
    [Abstract] [Full Text] [Related]

  • 35. Eplerenone in chronic heart failure with depressed systolic function.
    Volterrani M, Iellamo F.
    Int J Cardiol; 2015 Dec 01; 200():12-4. PubMed ID: 26044084
    [Abstract] [Full Text] [Related]

  • 36. Data-Driven Approach to Identify Subgroups of Heart Failure With Reduced Ejection Fraction Patients With Different Prognoses and Aldosterone Antagonist Response Patterns.
    Ferreira JP, Duarte K, McMurray JJV, Pitt B, van Veldhuisen DJ, Vincent J, Ahmad T, Tromp J, Rossignol P, Zannad F.
    Circ Heart Fail; 2018 Jul 01; 11(7):e004926. PubMed ID: 29997240
    [Abstract] [Full Text] [Related]

  • 37. Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms.
    Lee D, Wilson K, Akehurst R, Cowie MR, Zannad F, Krum H, van Veldhuisen DJ, Vincent J, Pitt B, McMurray JJ, Eplerenone in Mild Patients Hospitalization And Survival Study in Heart Failure (EMPHASIS-HF) Study.
    Heart; 2014 Nov 01; 100(21):1681-7. PubMed ID: 24993605
    [Abstract] [Full Text] [Related]

  • 38. Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy.
    Rossignol P, Ménard J, Fay R, Gustafsson F, Pitt B, Zannad F.
    J Am Coll Cardiol; 2011 Nov 01; 58(19):1958-66. PubMed ID: 22032706
    [Abstract] [Full Text] [Related]

  • 39. Hypo- and hyperglycemia predict outcome in patients with left ventricular dysfunction after acute myocardial infarction: data from EPHESUS.
    Ukena C, Dobre D, Mahfoud F, Kindermann I, Lamiral Z, Tala S, Rossignol P, Turgonyi E, Pitt B, Böhm M, Zannad F.
    J Card Fail; 2012 Jun 01; 18(6):439-45. PubMed ID: 22633301
    [Abstract] [Full Text] [Related]

  • 40. Eplerenone after myocardial infarction?
    Drug Ther Bull; 2008 Jan 01; 46(1):1-3. PubMed ID: 18171726
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.